[1] | Aartsma-Rus A, Ginjaar IB, Bushby K. The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet, 2016, 53(3): 145-151. | [2] | Bermejo-Pérez MJ, Márquez-Calderón S, Llanos-Méndez A. Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. Int J Cancer, 2007, 121(2): 225-231. | [3] | Padgett RA. New connections between splicing and human disease. Trends Genet, 2012, 28(4): 147-154. | [4] | Ars E, Serra E, García J, Kruyer H, Gaona A, Lázaro C, Estivill X. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet, 2000, 9(2): 237-247. | [5] | Soukarieh O, Gaildrat P, Hamieh M, Drouet A, Baert-Desurmont S, Frébourg T, Tosi M, Martins A. Exonic splicing mutations are more prevalent than currently estimated and can be predicted by using in silico tools. PLoS Genet, 2016, 12(1): e1005756. | [6] | Daguenet E, Dujardin G, Valcárcel J. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO Rep, 2015, 16(12): 1640-1655. | [7] | Singh RK, Cooper TA. Pre-mRNA splicing in disease and therapeutics. Trends Mol Med, 2012, 18(8): 472-482. | [8] | Kornblihtt AR, Schor IE, Alló M, Dujardin G, Petrillo E, Mu?oz MJ. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat Rev Mol Cell Biol, 2013, 14(3): 153-165. | [9] | Svenson IK, Ashley-Koch AE, Gaskell PC, Riney TJ, Cumming WJK, Kingston HM, Hogan EL, Boustany RMN, Vance JM, Nance MA, Pericak-Vance MA, Marchuk DA. Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet, 2001, 68(5): 1077-1085. | [10] | Teraoka SN, Telatar M, Becker-Catania S, Liang T, ?nengüt S, Tolun A, Chessa L, Sanal ?, Bernatowska E, Gatti RA, Concannon P. Splicing defects in the ataxia-telangiectasia gene,ATM: underlying mutations and consequences. Am J Hum Genet, 1999, 64(6): 1617-1631. | [11] | Mazoyer S, Puget N, Perrin-Vidoz L, Lynch HT, Serova-Sinilnikova OM, Lenoir GM. A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet, 1998, 62(3): 713-715. | [12] | Liu HX, Cartegni L, Zhang MQ, Krainer AR. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet, 2001, 27(1): 55-58. | [13] | Messiaen L, Callens T, De Paepe A, Craen M, Mortier G. Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene. Hum Genet, 1997, 101(1): 75-80. | [14] |
|
[1] |
宋绍征, 何正义, 成勇, 于宝利, 张婷, 李丹. TALENs介导MSTN基因突变山羊的制备及性能分析[J]. 遗传, 2022, 44(6): 531-542. |
[2] |
贾觉睿智, 肖诚, 刘艺文, 李冉, 张化冰, 于淼. 二例GCK基因突变致先天性高胰岛素性低血糖症的诊疗和基因检测分析[J]. 遗传, 2022, 44(11): 1056-1062. |
[3] |
肖诚, 刘洁颖, 杨春如, 于淼. LMNA基因突变相关脂肪萎缩综合征的研究进展[J]. 遗传, 2022, 44(10): 913-925. |
[4] |
蒋琬姿, 张丽雯, 贺彩红, 阮梅花, 季勇, 于建荣, 周红文. 家族性高胆固醇血症研究进展[J]. 遗传, 2021, 43(11): 1011-1022. |
[5] |
朱海美, 黄鹏程, 赵田田, 周长慧, 李若婉, 于春荣, 陈志勇, 顾林峰, 常艳. 纳米银颗粒及纳米二氧化钛颗粒的体外遗传毒性研究[J]. 遗传, 2020, 42(12): 1192-1200. |
[6] |
孙兆庆, 闫波. 转录因子GATA6在心血管疾病中的作用及其调控机制[J]. 遗传, 2019, 41(5): 375-383. |
[7] |
李楠, 李亚娟, 郭海滨, 张向前. Ds插入突变体的遗传学综合性实验设计与探讨[J]. 遗传, 2019, 41(12): 1148-1155. |
[8] |
徐福如, 蒋文君, 张涛, 姜倩, 张瑞雪, 毕宏生. FBN2基因突变与遗传性结缔组织病的发生[J]. 遗传, 2019, 41(10): 919-927. |
[9] |
严婷婷, 张蕾, 李余动, 梁新乐. 基于微信的“微生物遗传育种实验”混合式教学模式探究[J]. 遗传, 2018, 40(7): 601-606. |
[10] |
刘玉庆, 朱雄, 李姝锦, 杨业明, 杨牧, 赵培泉, 朱献军. 家族性渗出性玻璃体视网膜病变患者LRP5基因突变研究[J]. 遗传, 2017, 39(3): 241-249. |
[11] |
孙帅, 邓宇亮. 肺癌循环肿瘤细胞的单细胞EGFR基因突变检测[J]. 遗传, 2015, 37(12): 1251-1257. |
[12] |
陈晟 吴志英. 重复引物PCR技术在超大片段动态突变疾病基因检测中的应用进展[J]. 遗传, 2014, 36(11): 1145-1151. |
[13] |
郭奕斌. 基因诊断中测序技术的应用及优缺点[J]. 遗传, 2014, 36(11): 1121-1130. |
[14] |
刘亚兰, 张华, 冯永. 神经嵴发育异常导致综合征型耳聋的机制[J]. 遗传, 2014, 36(11): 1131-1144. |
[15] |
袁慧军, 卢宇. 新一代测序技术在遗传性耳聋基因研究及诊断中的应用[J]. 遗传, 2014, 36(11): 1112-1120. |
|